Literature DB >> 15264302

Biocompatibility and osseointegration of beta-TCP: histomorphological and biomechanical studies in a weight-bearing sheep model.

Holger E Koepp1, Sandra Schorlemmer, Stefan Kessler, Rolf E Brenner, Lutz Claes, Klaus-Peter Günther, Anita A Ignatius.   

Abstract

The aim of the study was to investigate the biocompatibility, degradation, and biomechanical properties of beta-TCP (Cerasorb) in a weight-bearing sheep model. beta-TCP implant prototypes were implanted in the tibial head of adult merino sheep. After 6 and 12 months material explants were harvested for biomechanical, histological, and histomorphometrical analysis. Corresponding bone specimens of the intact bone of the contralateral leg were used as controls in the biomechanical test. Compression tests showed higher values for maximum fracture load, yield strength, and compression modulus after 6 and 12 months compared to control. Microscopically, the implants showed good osteoconduction and were incorporated into the bone; however, relevant amounts of beta-TCP were still present after 12 months. Histomorphological results revealed that beta-TCP had partially degraded between implantation and 6 months, but its share remained constant between 6 and 12 months. The bone volume fraction in the area of the implant (46% +/- 6.5%) was initially higher than in the corresponding bone area of the contralateral leg (31% +/- 9.6%), but after 12 months declined to 29% +/- 9.4% (control: 33% +/- 8.3%), while the share of beta-TCP remained constant at 36% +/- 12.2%. These findings were supported by microradiographic data. In conclusion, in a weight bearing implantation model beta-TCP showed good biocompatibility, osseointegration and beginning degradation, even though it was not further degraded between 6 and 12 months. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15264302     DOI: 10.1002/jbm.b.30034

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  13 in total

Review 1.  [Bone substitutes].

Authors:  M Schieker; C Heiss; W Mutschler
Journal:  Unfallchirurg       Date:  2008-08       Impact factor: 1.000

2.  Ultrathin sP(EO-stat-PO) hydrogel coatings are biocompatible and preserve functionality of surface bound growth factors in vivo.

Authors:  Carl Neuerburg; Stefan Recknagel; Jörg Fiedler; Jürgen Groll; Martin Moeller; Kristina Bruellhoff; Heiko Reichel; Anita Ignatius; Rolf E Brenner
Journal:  J Mater Sci Mater Med       Date:  2013-06-26       Impact factor: 3.896

3.  Reconstructing jaw defects with MSCs and PLGA-encapsulated growth factors.

Authors:  Boon Ching Tee; Kashappa Goud H Desai; Kelly S Kennedy; Brittany Sonnichsen; Do-Gyoon Kim; Henry W Fields; Susan R Mallery; Steven P Schwendeman; Zongyang Sun
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

4.  Bone substitutes and implantation depths for subchondral bone repair in osteochondral defects of porcine knee joints.

Authors:  Tomohiko Matsuo; Keisuke Kita; Tatsuo Mae; Yasukazu Yonetani; Satoshi Miyamoto; Hideki Yoshikawa; Ken Nakata
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-02-01       Impact factor: 4.342

5.  Preparation, characterization and mechanical performance of dense beta-TCP ceramics with/without magnesium substitution.

Authors:  Xing Zhang; Fengchun Jiang; Todd Groth; Kenneth S Vecchio
Journal:  J Mater Sci Mater Med       Date:  2008-04-05       Impact factor: 3.896

6.  Bone augmentation using a new injectable bone graft substitute by combining calcium phosphate and bisphosphonate as composite--an animal model.

Authors:  Carsten W Schlickewei; Georg Laaff; Anne Andresen; Till O Klatte; Johannes M Rueger; Johannes Ruesing; Matthias Epple; Wolfgang Lehmann
Journal:  J Orthop Surg Res       Date:  2015-07-25       Impact factor: 2.359

7.  Glycosylated superparamagnetic nanoparticle gradients for osteochondral tissue engineering.

Authors:  Chunching Li; James Pk Armstrong; Isaac J Pence; Worrapong Kit-Anan; Jennifer L Puetzer; Sara Correia Carreira; Axel C Moore; Molly M Stevens
Journal:  Biomaterials       Date:  2018-05-21       Impact factor: 12.479

8.  Bone defect reconstruction with a novel biomaterial containing calcium phosphate and aluminum oxide reinforcement.

Authors:  Alexander M Keppler; Maximilian M Saller; Paolo Alberton; Ines Westphal; Frank Heidenau; Veronika Schönitzer; Wolfgang Böcker; Christian Kammerlander; Matthias Schieker; Attila Aszodi; Carl Neuerburg
Journal:  J Orthop Surg Res       Date:  2020-07-29       Impact factor: 2.359

9.  Chiral Tartaric Acid Improves Fracture Toughness of Bioactive Brushite-Collagen Bone Cements.

Authors:  Stylianos O Sarrigiannidis; Hanan Moussa; Oana Dobre; Matthew J Dalby; Faleh Tamimi; Manuel Salmeron-Sanchez
Journal:  ACS Appl Bio Mater       Date:  2020-07-06

10.  Implantation of canine umbilical cord blood-derived mesenchymal stem cells mixed with beta-tricalcium phosphate enhances osteogenesis in bone defect model dogs.

Authors:  Byung Jun Jang; Ye Eun Byeon; Ji Hey Lim; Hak Hyun Ryu; Wan Hee Kim; Yoshihisa Koyama; Masanori Kikuchi; Kyung Sun Kang; Oh Kyeong Kweon
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.